LSIL, Low Grade Squamous Intraepithelial Lesion Clinical Trials in Shatin, New Territories

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities